Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexey V Danilov

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Clinical Therapeutics|September 24, 2013
Targeted therapy in chronic lymphocytic leukemia: past, present, and futureAlexey V Danilov
British Journal of Haematology|November 20, 2020
Incorporating acalabrutinib, a selective next-generation Bruton tyrosine kinase inhibitor, into clinical practice for the treatment of haematological malignanciesAlexey V Danilov, Daniel O Persky
Therapeutic Advances in Hematology|April 2, 2021
The evolving role of Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemiaMax J Gordon, Alexey V Danilov
Current Oncology Reports|April 14, 2022
CAR T-Cell Therapy in the Older Person: Indications and RisksGeoffrey Shouse, Alexey V Danilov, Andy Artz
Expert Review of Anticancer Therapy|January 27, 2021
Duvelisib (Copiktra) in relapsed or refractory chronic lymphocytic leukemia: safety and efficacyLiana Nikolaenko, Tingting Liu, Alexey V Danilov
Oncotarget|October 22, 2021
Neddylation and anti-tumor immunityXiaoguang Wang, Scott Best, Alexey V Danilov
Current Hematologic Malignancy Reports|May 4, 2019
Relevance of Prognostic Factors in the Era of Targeted Therapies in CLLAdam S Kittai, Matthew Lunning, Alexey V Danilov
The Journal of Biological Chemistry|April 30, 2014
Gossypol increases expression of the pro-apoptotic BH3-only protein NOXA through a novel mechanism involving phospholipase A2, cytoplasmic calcium, and endoplasmic reticulum stressRyan S Soderquist, Alexey V Danilov, Alan Eastman
Current Hematologic Malignancy Reports|January 28, 2021
High-Risk Mantle Cell Lymphoma in the Era of Novel AgentsEdward Nabrinsky, Alexey V Danilov, Paul B Koller
The Oncologist|March 19, 2022
Translating the Biology of Diffuse Large B-cell Lymphoma Into TreatmentAlexey V Danilov, Massimo Magagnoli, Matthew J Matasar
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Clinical Therapeutics|September 24, 2013
Targeted therapy in chronic lymphocytic leukemia: past, present, and futureAlexey V Danilov
British Journal of Haematology|November 20, 2020
Incorporating acalabrutinib, a selective next-generation Bruton tyrosine kinase inhibitor, into clinical practice for the treatment of haematological malignanciesAlexey V Danilov, Daniel O Persky
Therapeutic Advances in Hematology|April 2, 2021
The evolving role of Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemiaMax J Gordon, Alexey V Danilov
Current Oncology Reports|April 14, 2022
CAR T-Cell Therapy in the Older Person: Indications and RisksGeoffrey Shouse, Alexey V Danilov, Andy Artz
Expert Review of Anticancer Therapy|January 27, 2021
Duvelisib (Copiktra) in relapsed or refractory chronic lymphocytic leukemia: safety and efficacyLiana Nikolaenko, Tingting Liu, Alexey V Danilov
Oncotarget|October 22, 2021
Neddylation and anti-tumor immunityXiaoguang Wang, Scott Best, Alexey V Danilov
Current Hematologic Malignancy Reports|May 4, 2019
Relevance of Prognostic Factors in the Era of Targeted Therapies in CLLAdam S Kittai, Matthew Lunning, Alexey V Danilov
The Journal of Biological Chemistry|April 30, 2014
Gossypol increases expression of the pro-apoptotic BH3-only protein NOXA through a novel mechanism involving phospholipase A2, cytoplasmic calcium, and endoplasmic reticulum stressRyan S Soderquist, Alexey V Danilov, Alan Eastman
Current Hematologic Malignancy Reports|January 28, 2021
High-Risk Mantle Cell Lymphoma in the Era of Novel AgentsEdward Nabrinsky, Alexey V Danilov, Paul B Koller
The Oncologist|March 19, 2022
Translating the Biology of Diffuse Large B-cell Lymphoma Into TreatmentAlexey V Danilov, Massimo Magagnoli, Matthew J Matasar
Pageof 12